Home / Health / Mounjaro Weight-Loss Jab Prices Soar 170% Globally
Mounjaro Weight-Loss Jab Prices Soar 170% Globally
14 Aug
Summary
- Mounjaro price rises from £122 to £330 per month
- NHS offers Mounjaro to obese patients despite price hike
- Pharmaceutical industry aligns prices across markets
As of August 14th, 2025, the price of the popular weight-loss injection Mounjaro has skyrocketed. The highest doses of this "King Kong" of weight-loss medicines will now cost £330 per month, a 170% increase from the previous price of £122.
This price hike comes as the pharmaceutical company Eli Lilly, the owner of Mounjaro, aligns the costs across global markets. The move reflects the industry's efforts to navigate policy changes in the United States, which has historically paid significantly more for prescription drugs compared to other developed nations.
Despite the substantial price increase, the NHS in the UK will continue offering Mounjaro to obese patients. In June 2025, the NHS began providing the treatment to individuals with a BMI over 40 and at least four weight-related health conditions, such as heart disease or type 2 diabetes. Over the next three years, an estimated 240,000 patients are expected to be eligible for the Mounjaro treatment through the NHS.
The National Institute for Health and Care Excellence (NICE) has also issued guidance emphasizing the importance of providing structured advice and follow-up support to patients who cease the Mounjaro treatment, in order to mitigate potential weight regain.
